Debates between Yasmin Qureshi and Maria Caulfield during the 2019 Parliament

Hormone Pregnancy Tests

Debate between Yasmin Qureshi and Maria Caulfield
Thursday 7th September 2023

(7 months, 3 weeks ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Maria Caulfield Portrait Maria Caulfield
- Hansard - - - Excerpts

Will the hon. Lady give way?

Yasmin Qureshi Portrait Yasmin Qureshi
- Hansard - -

We want to sit down with the Minister, and we want her to say to us, “This is what we are going to do about the Primodos case.” We do not want the Minister to tell us the problems. We want a system of redress right now—that is what we want from the Minister—and I hope that when we have that meeting, she and her officials will present to us the practical action they are going to take so that all the people who have been suffering for decades and decades actually get justice. We want her to tell us not about what has happened before or about the court cases, but about the actions she will take based on what the Cumberlege review said. [Interruption.] The Minister is muttering, but in the past it has sometimes taken us months and months to get a meeting with Ministers. I am glad that she has reassured us, and I hope that we will get a meeting in the next couple of weeks and that her and her officials will present a concrete plan for how to get redress for the victims. [Interruption.]

Yasmin Qureshi Portrait Yasmin Qureshi
- Hansard - -

I am sorry; I did not realise the Minister was asking to intervene. I give way.

Maria Caulfield Portrait Maria Caulfield
- Hansard - - - Excerpts

I just wanted to reiterate that I have pledged to meet the APPG and all its members. I have also pledged to look at the recommendations specifically in relation to Primodos. I think it is important to meet the families and the APPG, so that we can make progress on this issue.

Yasmin Qureshi Portrait Yasmin Qureshi
- Hansard - -

I thank the Minister for that intervention. I look forward to meeting her and her officials, and to a great scheme that will help the victims of Primodos. I remind her that if we do not get our meeting, or if we do not get a satisfactory result, we will be back again—all of us. We have been fighting for the past 10 or 12 years, and we will continue to fight this campaign, because the whole House is united behind it. I hope we will get positive news at our next meeting.

Question put and agreed to.

Resolved,

That this House notes that children were born with serious deformities due to the hormone pregnancy test drug Primodos, which was taken by expectant mothers between 1953 and 1975; further notes that official warnings were not issued about Primodos until eight years after the first reports indicated possible dangers; observes that the report by the Commission on Human Medicines’ Expert Working Group on Hormone Pregnancy Tests in 2017 was inconsistent with other academic reports; notes that the Independent Medicines and Medical Devices Safety Review, First do no harm, found that Primodos caused avoidable harm; further notes that the Government has refused to acknowledge the recommendations by the Independent Medicines and Medical Devices Safety Review relating to Primodos families; and calls on the Government to fully implement the recommendations in the Independent Medicines and Medica al Devices Safety Review and to set up a redress fund for families affected by Primodos.

Oral Answers to Questions

Debate between Yasmin Qureshi and Maria Caulfield
Wednesday 8th March 2023

(1 year, 1 month ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Yasmin Qureshi Portrait Yasmin Qureshi (Bolton South East) (Lab)
- View Speech - Hansard - -

Pregnant women who live in the poorest areas of England are twice as likely to die than those living in the most affluent areas. Shockingly, black women are four times more likely to die during childbirth. This Government have had 13 years, but have failed to tackle maternal health inequalities. What action is the Minister taking to address these appalling disparities?

Maria Caulfield Portrait Maria Caulfield
- View Speech - Hansard - - - Excerpts

This is why we have set up the maternity disparities taskforce. We are working with the chief midwife to drive down those disparities, and we are working with NHS England. Maternity is one of those Core20PLUS5 elements, because we recognise that there is huge disparity across the country, which we want to eliminate.

Oral Answers to Questions

Debate between Yasmin Qureshi and Maria Caulfield
Wednesday 30th November 2022

(1 year, 5 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Maria Caulfield Portrait Maria Caulfield
- View Speech - Hansard - - - Excerpts

Of course, the health disparities White Paper is important, but work has already started on disparities. As I set out, the NHS has already launched the Core20PLUS5, where the 20% most deprived communities are being targeted with interventions in the five most clinically significant areas. Those are maternity, mental health, respiratory disease, cancer and hypertension. Work has already started, and I know that that is of particular interest in areas such as Stoke.

Yasmin Qureshi Portrait Yasmin Qureshi (Bolton South East) (Lab)
- Hansard - -

A new World Health Organisation study, published in The Lancet, found that poorer women in Britain have some of the highest cancer death rates in Europe. Income levels should not be the marker of someone’s chances of getting and dying from cancer. Does the Minister recognise that that is not acceptable, and will she commit to a cross-Government strategy that tackles health inequalities?

Maria Caulfield Portrait Maria Caulfield
- View Speech - Hansard - - - Excerpts

I refer the shadow Minister to the work that the Government are already doing. Cancer in particular is one of the five core areas in which we are investing significant resources to diagnose people earlier. She may be interested in the lung cancer detection vans, which go to those communities with the highest incidence rates and poorer outcomes for lung cancer. Some 70% of people with stage 1 or 2 cancer are being detected, significantly improving their life expectancy.